Possibilities and advantages of additive manufacturing in dry powder formulations for inhalation
European Journal of Pharmaceutical Sciences · 2023-11 · 190 · 106583
DOI: 10.1016/j.ejps.2023.106583 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2023-11. Verfasst von Melvin Wostry und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Biopharmaceutics, Kiel University, Grasweg 9a, Kiel 24118, Germany. Hauptthemen laut MEDLINE: Drug Carriers, Chemistry, Pharmaceutical. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In dry powder formulations for inhalation, coarse carrier particles are often used to improve handling, dosing and dispersion of the active pharmaceutical ingredient (API). Carrier particles, mostly alpha-lactose monohydrate crystals, always show a certain size distribution and are never exactly uniform in their geometry. This might be one factor of the rather high invivo variability in fine particle dose from dry powder inhalers. To address the inhomogeneity of carrier particles, additive manufacturing has come to mind. The parametric design of the perfect carrier geometry could further improve the efficiency of dry powder formulations. In this study, a numerical simulation setup using the discrete element method as well as an experimental approach with 3D printed particles were used to determine the loading capacity of a model API onto two different carrier geometries. The difference between the two geometries was reduced solely to their surface's topology to assess the impact of that. The results indicate differences in the loading capacity for the two geometries, depending on the loading process. This study highlights the importance of the carrier geometry for the efficiency of dry powder formulations and thus, strengthens the idea of artificially designed and printed carrier particles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics and Biopharmaceutics, Kiel University, Grasweg 9a, Kiel 24118, Germany.
- Department of Pharmaceutics and Biopharmaceutics, Kiel University, Grasweg 9a, Kiel 24118, Germany; Priority Research Area Kiel Nano, Surface and Interface Sciences (KiNSIS), Kiel University, Kiel, Germany. Electronic a…
Zitieren
APA
Wostry, M., & Scherließ, R. (2023). Possibilities and advantages of additive manufacturing in dry powder formulations for inhalation. European Journal of Pharmaceutical Sciences, 190, 106583. https://doi.org/10.1016/j.ejps.2023.106583
Vancouver
Wostry M, Scherließ R. Possibilities and advantages of additive manufacturing in dry powder formulations for inhalation. European Journal of Pharmaceutical Sciences. 2023;190:106583. doi:10.1016/j.ejps.2023.106583
BibTeX
@article{Wostry2023,
author = {Wostry, Melvin and Scherließ, Regina},
title = {Possibilities and advantages of additive manufacturing in dry powder formulations for inhalation},
journal = {European Journal of Pharmaceutical Sciences},
year = {2023},
volume = {190},
pages = {106583},
doi = {10.1016/j.ejps.2023.106583}
}
EUVIMED